These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7791830)

  • 1. Interleukin-2 as therapy for HIV disease. Dinitrochlorobenzene Study Group.
    Goldberg B
    N Engl J Med; 1995 Jul; 333(3):192; author reply 193. PubMed ID: 7791830
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-2 as therapy for HIV disease.
    Landonio G; Baiocchi C; Ferrari M
    N Engl J Med; 1995 Jul; 333(3):192-3. PubMed ID: 7791831
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-2 as therapy for HIV disease.
    Disla E
    N Engl J Med; 1995 Jul; 333(3):192; author reply 193. PubMed ID: 7646690
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2 injections produce sustained increases in CD4+ T cell counts in early-stage HIV disease.
    AIDS Patient Care STDS; 1996 Oct; 10(5):312. PubMed ID: 11361533
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of HIV infection: combination drug therapy effective, immunotherapy still experimental].
    Dtsch Med Wochenschr; 1997 Apr; 122(15):A32. PubMed ID: 9147936
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.
    De Paoli P; Zanussi S; Simonelli C; Bortolin MT; D'Andrea M; Crepaldi C; Talamini R; Comar M; Giacca M; Tirelli U
    J Clin Invest; 1997 Dec; 100(11):2737-43. PubMed ID: 9389737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is immune boosting the next step?
    Grodeck B
    Posit Aware; 1997; 8(1):18-9. PubMed ID: 11364092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will immune-based therapies ever be approved?
    Lein B
    Res Initiat Treat Action; 2002; 8(1):26-9. PubMed ID: 12489524
    [No Abstract]   [Full Text] [Related]  

  • 9. IL-2: controlled trial finds major CD4 increases.
    James JS
    AIDS Treat News; 1996 Nov; (No 258):3-4. PubMed ID: 11363996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encouraging data on quality of life reported for IL-2 therapy.
    AIDS Patient Care STDS; 1996 Oct; 10(5):314-5. PubMed ID: 11361537
    [No Abstract]   [Full Text] [Related]  

  • 11. New strategies to combat HIV: augmenting antiviral immunity.
    Smith KA; Boyle BA
    AIDS Read; 2003 Aug; 13(8):365-9, 382. PubMed ID: 14524321
    [No Abstract]   [Full Text] [Related]  

  • 12. IL-2 plus HAART reduces HIV in immune system "hiding places".
    WORLD; 1998 Dec; (No 92):7. PubMed ID: 11365976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of immunity with interleukin-2 therapy.
    Smith KA; Jacobson EL; Emert R; Giordano M; Kovacs E; Mumneh N; Pilaro F; Sohn T; Warren D
    AIDS Read; 1999 Nov; 9(8):563-72. PubMed ID: 11082734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A look at HIV immune research. Interview by Alan Huff.
    Landay A
    Res Initiat Treat Action; 2000 Sep; 6(3):30-3. PubMed ID: 11708165
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients.
    Herzmann C; Cuthbertson Z; Fosdick L; Fisher M; Nelson M; Perry N; Law M; Wand H; Janossy G; Johnson MA; Youle M
    J Antimicrob Chemother; 2008 Sep; 62(3):583-6. PubMed ID: 18587135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing CD4 count with interleukin-2 does not benefit people with HIV.
    Roehr B
    BMJ; 2009 Feb; 338():b615. PubMed ID: 19218320
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of interleukin-2 therapy on the viral reservoir in HIV+ patients.
    Zanussi S; De Paoli P
    Biomed Pharmacother; 2000 Jul; 54(6):316-20. PubMed ID: 10989965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nadir CD4+ T cell count predicts response to subcutaneous recombinant interleukin-2.
    Markowitz N; Bebchuk JD; Abrams DI;
    Clin Infect Dis; 2003 Oct; 37(8):e115-20. PubMed ID: 14523786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia.
    Simonelli C; Zanussi S; Comar M; Vaccher E; Giacca M; De Paoli P; Tirelli U
    AIDS; 1998 Jan; 12(1):112-3. PubMed ID: 9456263
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin 2 and HIV RNA Levels.
    Go R; Steigbigel R
    Arch Intern Med; 2007 Oct; 167(19):2144-5; author reply 2145. PubMed ID: 17954814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.